New drug cocktail tested for aggressive lymphomas
Disease control
Ongoing
This early-stage study is testing a combination of three drugs—obinutuzumab, venetoclax, and lenalidomide—in patients whose B-cell non-Hodgkin lymphoma has come back or hasn't responded to previous treatments. The main goal is to find the safest and most effective dose of the dru…
Phase: PHASE1 • Sponsor: Beth Christian • Aim: Disease control
Last updated Apr 02, 2026 00:41 UTC